Perceptually Calibrated Scale of Optical Aberrations
SOOA
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
The main objective of the project is to develop a new, more reliable method of modeling and parametrization of the halo and glare phenomena based on the subjective perception of these visual disturbances. The project will consist of three parts. The first will include the psychophysical measurement of glare and halo phenomena perceived by people with multifocal corrective lenses compared to the reference group. The second part will focus on the development of an algorithm for the generation of optical elements (masks) inducing standard halo and glow effects of a given size and intensity. The third phase of the project will concern the calibration of the developed algorithm. For this purpose, the halo and glare will be induced by the developed masks in the healthy eye, so as to match them with the vision disorders measured in the first part of the project in people using multifocal vision correction methods. As a result of this research, a scale for precise measurement of subjective halo and glare phenomena in the field of view will be created, independently covering their intensity and size, and in the future allowing for optical (and not graphic simulation as in commercially available simulators) simulation of scenes seen by patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2022
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2022
CompletedFirst Posted
Study publicly available on registry
August 25, 2022
CompletedStudy Start
First participant enrolled
September 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedAugust 30, 2022
August 1, 2022
4 months
January 13, 2022
August 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
presence of optical aberrations in analyzed eyes
halo and glare presence in analyzed eyes
up to 3 months
Study Arms (2)
multifocal lens
EXPERIMENTALexamination of dysphotopsia
control group
ACTIVE COMPARATORexamination of dysphotopsia
Interventions
diagnostic of optical aberrations with new device
Eligibility Criteria
You may qualify if:
- Adult males and females, of any race
- one or both eyes with implanted intraocular monofocal lens (10 eyes) and multifocal lens (10 eyes)
- informed consent to participate in the study
- presence at scheduled follow-up visits after the procedure for a period of 24 months.
You may not qualify if:
- in the eye qualified for the test:
- cataract
- Fuchs dystrophy and other corneal diseases
- evidence of serious eye disease
- ophthalmic surgeries other than cataract surgery
- clinically active or past uveitis
- intraocular pressure (IOP) \>21 mmHg
- glaucoma
- retinal detachment or its suspicion in ultrasound examination of the eyeball
- systemic diseases with ocular symptoms, including diseases that may affect the function of corneal endothelial cells
- intolerance of the examination in the slit lamp or other procedures planned in the examination
- pregnancy
- mental disorders or emotional instability to an extent that does not allow the subject's informed consent in the study and presence at scheduled follow-up visits
- documented sensitivity to pharmacological agents used in the study, i.e. topical anesthetics, fluorescein, other related to the ophthalmological examination serious fatal illnesses or a patient's medical condition preventing the study from continuing for a period of 6 months
- current participation in other research programs
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Song X, Liu X, Wang W, Zhu Y, Qin Z, Lyu D, Shentu X, Xv W, Chen P, Ke Y. Visual outcome and optical quality after implantation of zonal refractive multifocal and extended-range-of-vision IOLs: a prospective comparison. J Cataract Refract Surg. 2020 Apr;46(4):540-548. doi: 10.1097/j.jcrs.0000000000000088.
PMID: 32213781BACKGROUNDCarson D, Lee S, Alexander E, Wei X, Lee S. Comparison of two laboratory-based systems for evaluation of halos in intraocular lenses. Clin Ophthalmol. 2018 Feb 21;12:385-393. doi: 10.2147/OPTH.S152201. eCollection 2018.
PMID: 29503526BACKGROUNDSavini G, Schiano-Lomoriello D, Balducci N, Barboni P. Visual Performance of a New Extended Depth-of-Focus Intraocular Lens Compared to a Distance-Dominant Diffractive Multifocal Intraocular Lens. J Refract Surg. 2018 Apr 1;34(4):228-235. doi: 10.3928/1081597X-20180125-01.
PMID: 29634837BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Karolina Krix-Jachym, MD PhD
Military Institute of Warsaw, Poland
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 13, 2022
First Posted
August 25, 2022
Study Start
September 9, 2022
Primary Completion
December 29, 2022
Study Completion
December 30, 2022
Last Updated
August 30, 2022
Record last verified: 2022-08